Monoravir capsules (molnupiravir) Chinese instructions
Molnupiravir capsules (Molnupiravir) is an antiviral drug used to treat COVID-19.
1. Indications: Monoravir capsules are used to treatCOVID-19, a coronavirus disease caused by a new coronavirus (SARS-CoV-2). It is suitable for adult patients with confirmed COVID-19 infection, especially in early cases, to help reduce symptoms and reduce the risk of hospitalization.
2. Mechanism of action: The mechanism of action of monogravir capsules is to interfere with the RNA replication of the virus by simulating nucleoside analogues. It blocks viral growth in the early stages of viral replication, thereby reducing viral load and mitigating the symptoms and spread of COVID-19.
3. Pharmacology: Monoravir capsules are absorbed after oral administration and are subsequently metabolized into active metabolites. These metabolites inhibit viral replication by inhibiting viralRNApolymerase. It is particularly effective in early stages of infection, reducing the spread of the virus.
4. Dosage and Usage: The standard dosage of monogravir capsules is: take orally daily < /span>800mg, divided into two times, each time 400mg, taken continuously for 5 days. Doctor's prescriptions and recommendations should be followed.
5. Side effects
Monoravir capsules may be associated with some side effects, including but not limited to: nausea and vomiting, diarrhea, headache, fatigue, abnormal liver function, heart-related problems, etc. Please note that the severity and frequency of side effects vary among individuals.
6. Warnings and Precautions
Monoravir capsules should not be used if you are not infectedwith COVID-19.
Women should use it with caution during pregnancy or lactation and under the guidance of a doctor.
Patients with liver disease need special caution and may need regular monitoring of liver function.
Patients with heart problems should use it with caution and monitor heart-related indicators.
Discuss any history of drug allergies and possible allergic reactions with your doctor.
7. Contraindications
Monoravir capsules are contraindicated in the following circumstances:
Patients with known allergies to ingredients in the drug.
Children and adolescents (under18 years of age).
8. Drug Interactions: Monoravir capsules may interact with other drugs. Before starting use, tell your doctor about any medications you are taking, including prescription drugs, over-the-counter drugs, vitamins, and supplements. Your doctor will evaluate potential interactions and make adjustments.
9. Drug use for special groups
Pregnant and lactating women should use it under the guidance of a doctor.
Monoravir capsules are not suitable for use in children and adolescents under18 years of age.
In older adults, dosage adjustments may be needed based on renal function and other factors.
Patients with abnormal hepatic function may require special monitoring and dose adjustments.
10.Launch and price situation: Monolavir capsules have been launched in China, but they have not been included in medical insurance. Please consult the local hospital pharmacy for specific prices. The cheaper ones abroad are Indian generic drugs, which cost around three to four hundred yuan, and the ingredients of domestic original drugs and foreign generic drugs are basically the same.
In summary, monogravir capsules are a drug used to treatCOVID-19 and are suitable for early cases of infection to help reduce symptoms and reduce the risk of hospitalization. However, you should read the instructions carefully before use, follow your doctor's prescriptions and recommendations, and understand possible side effects, warnings, and precautions to ensure safe and effective use. Also, discuss any concerns or special circumstances with your doctor to receive the best medical care.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)